# Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis

> **NCT00604682** · PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 19 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** CC10004

## Key facts

- **NCT ID:** NCT00604682
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-01
- **Primary completion:** 2005-10-01
- **Final completion:** 2005-12-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2020-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00604682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00604682, "Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00604682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*